Publications

2019

• Fukuyama Cross-Coupling Approach to Isoprekinamycin: Discovery of the Highly Active and Bench-Stable Palladium Precatalyst POxAP 
  Tang S.-Q., Bricard J., Schmitt M., Bihel F.,*
  Organic Letters (2019) 21, 3, 844-848 (DOI : 10.1021/acs.orglett.9b00031)
  Post-print on HAL

• On water N-arylation of oxetanylamines for the preparation of N-aryl-oxetanylamines; potentially useful aryl-amide isosteres
  Bollenbach M, Lecroq W, Wagner P, Fessard T, Schmitt M, Salomé C
  Chemical Communication (2019) 55, 1623-1626 (DOI : 10.1039/C8CC09110B)

• Design and synthesis of 3-aminophthalazine derivatives and structural analogues as PDE5 inhibitors: anti-allodynic effect against neuropathic pain in a mouse model
  Bollenbach, M., Lugnier, C., Kremer, M., Salvat, E., Megat, S., Bihel, F., Bourguignon, J.-J., Barrot, M., and Schmitt
  European Journal of Medicinal Chemistry (2019) 177, 269–290. DOI: 10.1016/j.ejmech.2019.05.026
  Post-print on HAL

• Mitochondria modulatory effects of new TSPO ligands in a cellular model of tauopathies.
  Grimm, A., Lejri, I., Hallé, F., Schmitt, M., Götz, J., Bihel, F., and Eckert, A.
  Journal of Neuroendocrinology (2019) DOI: 10.1111/jne.12796

• TSPO ligands boost mitochondrial function and pregnenolone synthesis. 
  Lejri, I., Grimm, A., Hallé, F., Abarghaz, M., Klein, C., Maitre, M., Schmitt, M., Bourguignon, J.-J., Mensah-Nyagan, A.G., Bihel, F., Eckert A.
  Journal of Alzheimer’s Disease (2019) DOI: 10.3233/JAD-190127

• Evolution of coumaroyl conjugate 3‐hydroxylases in land plants: Lignin biosynthesis and defense.
  Alber, A.V., Renault, H., Basilio Lopes, A., Bassard, J., Liu, Z., Ullmann, P., Lesot, A., Bihel, F., Schmitt, M., Werck‐Reichhart, D., Ehlting J.
  The Plant Journal (2019) DOI: 10.1111/tpj.14373

2018

• Dioxygenation of Styrenes with Molecular Oxygen in Water.
  Tang, S.-Q., Wang, A.-P., Schmitt, M., Bihel, F.,*
  Tetrahedron Letters 59, 1465–1468
  https://doi.org/10.1016/j.tetlet.2018
  
  
• Heteroarylguanidines as Allosteric Modulators of ASIC1a and ASIC3 Channels.
  Alijevic, O., Hammoud, H., Vaithia, A., Trendafilov, V., Bollenbach, M., Schmitt, M., Bihel, F.,* Kellenberger, S.* 
  ACS Chemical Neuroscience 9, 6, 1357-1365
  https://doi.org/10.1021/acschemneuro.7b00529
  
  
• Aminoguanidine hydrazone derivatives as non-peptide NPFF1 receptor antagonists reverse opioid induced hyperalgesia.
  Hammoud, H., Elhabazi, K., Quillet, R., Bertin, I., Utard, V., Laboureyras, E., Bourguignon, J.-J., Bihel, F., Simonnet, G., Simonin, F.,* Schmitt, M.,*
  ACS Chemical Neuroscience 9, 11, 2599-2609
  https://doi.org/10.1021/acschemneuro.8b00099.03.009
  
  
• Phenylpyridine-2-ylguanidines and rigid mimetics as novel inhibitors of TNFα overproduction: Beneficial action in models of neuropathic pain and of acute lung inflammation. 
  Bollenbach, M., Salvat, E., Daubeuf, F., Wagner, P., Yalcin, I., Humo, M., Letellier, B., Becker, L.J., Bihel, F., Bourguignon, J.-J., Villa, P., Obrecht, A., Frossard, N., Barrot, M., Schmitt, M.,* 
  European Journal of Medicinal Chemistry 23, 13676–13683
  https://doi.org/10.1016/j.ejmech.2018.01.049
  
  
• Human erythrocytes release ATP by a novel pathway involving VDAC oligomerization independent of pannexin-1.
  Marginedas-Freixa, I., Alvarez, C.L., Moras, M., Leal Denis, M.F., Hattab, C., Halle, F., Bihel, F., Mouro-Chanteloup, I., Lefevre, S.D., Le Van Kim, C., Schwarzbaum, P.J., Ostuni, M.A. 
  Scientific Reports 8, 11384 https://doi.org/10.1038/s41598-018-29885-7
  
  
• A bifunctional-biased mu-opioid agonist–neuropeptide FF receptor antagonist as analgesic with improved acute and chronic side effects
  Drieu la Rochelle, A., Guillemyn, K., Dumitrascuta, M., Martin, C., Utard, V., Quillet, R., Schneider, S., Daubeuf, F., Willemse, T., Mampuys, P., Maes, B.U.W., Frossard, N., Bihel, F., Spetea, M., Simonin, F., Ballet, S. 
  PAIN 159, 9, 1705-1718
  https://doi.org/10.1097/j.pain.0000000000001262
  
  
• Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in mice.
  Rivat, C., Sar, C., Mechaly, I., Leyris, J.-P., Diouloufet, L., Sonrier, C., Philipson, Y., Lucas, O., Mallié, S., Jouvenel, A., Tassou, A., Haton, H., Venteo, S., Pin, J.-P., Trinquet, E., Charrier-Savournin, F., Mezghrani, A., Joly, W., Mion, J., Schmitt, M., Pattyn, A., Marmigère, F., Sokoloff, P., Carroll, P., Rognan, D., Valmier, J.,
  Nature Communications 9, 1042
  https://doi.org/10.1038/s41467-018-03496-2
  
  
• Evidence for the involvement of TNF-α, IL-1β and IL-10 in the antinociceptive and anti-inflammatory effects of indole-3-guanylhydrazone hydrochloride, an aromatic aminoguanidine, in rodents.
  Sandes, S.M.S., Heimfarth, L., Brito, R.G., Santos, P.L., Gouveia, D.N., Carvalho, A.M.S., Quintans, J.S.S., da Silva-Júnior, E.F., de Aquino, T.M., França, P.H.B., de Araújo-Júnior, J.X., Albuquerque-Júnior, R.L.C., Zengin, G., Schmitt, M., Bourguignon, J.-J., Quintans-Júnior, L.J.,
  Chemico-Biological Interactions 286, 1–10.
  https://doi.org/10.1016/j.cbi.2018.02.026

2017

• Efficient and mild Ullmann-type N-arylation of amides, carbamates, and azoles in water.
  Bollenbach, M., Aquino, P.G.V., de Araujo-Junior, J.X., Bourguignon, J.-J., Bihel, F., Salome, C., Wagner, P., Schmitt, M.*  
  Chemistry - A European Journal 23, 13676–13683. https://doi.org/10.1002/chem.201700832
  
  
• RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents.
  Elhabazi, K., Humbert, J.-P., Bertin, I., Quillet, R., Utard, V., Schmitt, M., Bourguignon, J.-J., Laboureyras, E., Ben Boujema, M., Simonnet, G., Ancel, C., Simonneaux, V., Beltramo, M., Bucher, B., Sorg, T., Meziane, H., Schneider, E., Petit-Demoulière, B., Ilien, B., Bihel, F.,* Simonin, F.*  Neuropharmacology 118, 188–198. https://doi.org/10.1016/j.neuropharm.2017.03.012
  
  
• Discovery of Imidazoquinazolinone Derivatives as TSPO Ligands Modulating Neurosteroidogenesis and Cellular Bioenergetics in Neuroblastoma Cells Expressing Amyloid Precursor Protein.
  Hallé, F., Lejri, I., Abarghaz, M., Grimm, A., Klein, C., Maitre, M., Schmitt, M., Bourguignon, J.-J., Mensah-Nyagan, A.G., Eckert, A.*, Bihel, F.*
  ChemistrySelect 2, 6452–6457. https://doi.org/10.1002/slct.201701565
  
  
• The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis.
  Leva, G., Klein, C., Benyounes, J., Hallé, F., Bihel, F., Collongues, N., Seze, J.D., Mensah-Nyagan, A.-G., Patte-Mensah, C.
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/https://doi.org/10.1016/j.bbadis.2017.09.007
  
  
• Development of a L-Tryptophan-Based Ligand for Regioselective Copper Catalyzed N 2 -Arylation of 1,2,3-Triazoles.
  Lopes, A.B., Wagner, P., Kümmerle, A.E., Bihel, F., Bourguignon, J.-J., Schmitt, M., Miranda, L.S.M.  ChemistrySelect 2, 6544–6548. https://doi.org/10.1002/slct.201701498
  
  
• χ-Space Screening of Dermorphin-Based Tetrapeptides through Use of Constrained Arylazepinone and Quinolinone Scaffolds.
  Van der Poorten, O., Van Den Hauwe, R., Eiselt, E., Betti, C., Guillemyn, K., Chung, N.N., Hallé, F., Bihel, F., Schiller, P.W., Tourwé, D., Sarret, P., Gendron, L., Ballet, S.,
  ACS Medicinal Chemistry Letters 8, 1177–1182. https://doi.org/10.1021/acsmedchemlett.7b00347
  
  
• A phenol-enriched cuticle is ancestral to lignin evolution in land plants
  Renault, H., Alber, A., Horst, N.A., Basilio Lopes, A., Fich, E.A., Kriegshauser, L., Wiedemann, G., Ullmann, P., Herrgott, L., Erhardt, M., Pineau, E., Ehlting, J., Schmitt, M., Rose, J.K.C., Reski, R., Werck-Reichhart, D., 
  Nature Communications 8, 14713. https://doi.org/10.1038/ncomms14713

2016

• D-glucose : An efficient reducing agent for a Copper(II) mediated arylation of primary amines in water
  Bollenbach M, Wagner P, Aquino P, Bourguignon J-J, Bihel F, Salomé C, and Schmitt M
  ChemSusChem 2016, 9, 3244-3249
  
  
• RF-Amide Neuropeptides And Their Receptors In Mammals : Pharmacological Properties, Drug Development And Main Physiological Functions.
  Quillet R, Ayachi S, Bihel F, Elhabazi K, Ilien B and Simonin F
  Pharmacol Ther. 2016, 160, 84-132
  

• Opioid adjuvant strategy : improving opioid effectiveness
  Bihel F
  Future Med. Chem. 2016, 8, 339-354

• Synthesis of 3-amino-3,4-dihydro-1H-quinolin-2-ones through regioselective palladium-catalyzed intramolecular cyclization
  Hallé F., Van Der Poorten O., Doebelin C., Niederst M., Schneider S, Schmitt M., Ballet S., Bihel F.
  Tetrahedron Letters 2016, 57, 1547-1550

• The effect of Neuropeptide FF in the amygdala kindling model
  Buffel I., Meurs A., Portelli J., Raedt R., De Herdt V., Poppe L., De Meulenaere V., Wadmann W., Bihel F., Schmitt M., Vonck K., Bourguignon J.J., Simonin F., Smolders I., Boon P.
  Acta Neurologica Scandinavica 2016, 134, 181-188

• CMTX disorder and CamKinase
  Bihel F, Burkhard G, Fontes M
  Front. Cell. Neurosci. 2016, 10

• Development of Dipeptidic hGPR54 Agonists
  C. Doebelin, I. Bertin, S. Schneider, M. Schmitt, J.-J. Bourguignon, C. Ancel, V. Simonneaux, F. Simonin, F. Bihel,
  ChemMedChem 2016, 11, 2147-2154.

• TSPO ligands stimulate ZnPPIX transport and ROS accumulation leading to the inhibition of P. falciparum growth in human blood
  Marginedas-Freixa, I.;Hattab, C.;Bouyer, G.;Halle, F.;Chene, A.;Lefevre, S. D.;Cambot, M.;Cueff, A.;Schmitt, M.;Gamain, B.;Lacapere, J. J.;Egee, S.;Bihel, F.;Le Van Kim, C. and Ostuni, M. A.
  Scientific Reports 2016, 6, 33516

2015

• Rapid and scalable synthesis of innovative unnatural α,β or γ-amino acids functionalized with tertiary amines on their side-chains.
  Schneider S, Ftouni H, Niu S, Schmitt M, Simonin F, Bihel F.
  Org Biomol Chem. 2015, 13(25), 7020-7026.

• Development of a peptidomimetic antagonist of neuropeptide FF receptors for the prevention of opioid-induced hyperalgesia
  Bihel, F.; Humbert, JP.; Schneider, S.; Bertin, I.; Wagner, P.; Schmitt, M.; Laboureyras, E.; Petit-Demoulière, B.; Schneider, E.; Mollereau, C.; Simonnet, G.; Simonin, F. and Bourguignon J.J.
  ACS Chem Neuroscience 2015, 6(3), 438-45

• Effects of systematic N-terminus deletions and benzoylations of endogenous RF-amide peptides on NPFF1R, NPFF2R, GPR10, GPR54 and GPR103.
  Rouméas, L.; Humbert, J.-P.; Schneider, S.; Doebelin, C.; Bertin, I.; Schmitt, M.; Bourguignon, J.-J.; Simonin, F.; Bihel, F.
  Peptides 2015, 71, 156-161.

• Neuropeptide FF receptors as novel targets for limbic seizure attenuation.
  Portelli J, Meurs A, Bihel F, Hammoud H, Schmitt M, De Kock J, Utard V, Humbert JP, Bertin I, Buffel I, Coppens J, Tourwe D, Maes V, De Prins A, Vanhaecke T, Massie A, Balasubramaniam A, Boon P, Bourguignon JJ, Simonin F, Smolders I.
  Neuropharmacology. 2015, 95, 415-423

• Neuropeptide FF and prolactin releasing peptide decrease cortical excitability through activation of NPFF receptors
  Buffel, I.; Meurs, A.; Portelli, J.; Raedt, R.; De Herdt, V.; Sioncke, L.; Wadman, W.; Bihel, F.; Schmitt, M.; Vonck, K.; Bourguignon, J.-J.; Simonin, F.; Smolders, I. and Boon, P.
  Epilepsia 2015, 56(3), 489-98

• The long-lasting love affair between the budding yeast Saccharomyces cerevisiae and the Epstein-Barr virus.
  Lista, M. J.; Voisset, C.; Contesse, M.-A.; Friocourt, G.; Daskalogianni, C.; Bihel, F.; Fåhraeus, R.; Blondel, M.
  Biotechnology Journal 2015, 16(11) 1670-1681

• Design and validation of a homogeneous time-resolved fluorescence cell-based assay targeting the ligand-gated ion channel 5-HT3A.
  Blanc E, Wagner P, Plaisier F, Schmitt M, Durroux T, Bourguignon JJ, Partiseti M, Dupuis E, Bihel F.
  Anal Biochem. 2015, 484, 105-112
  

• A Yeast/Drosophila screen to identify new compounds overcoming frataxin deficiency
  Seguin, A.; Monnier, V.; Palandri, A.; Bihel, F.; Rera, M.; Schmitt, M.; Camadro, J.-M.; Tricoire, H. and Lesuisse E.
  Oxidative Medicine and Cellular Longevity 2015, 565140

• CMTX1 patients' cells present genomic instability corrected by CamKII inhibitors
  Mones, S.; Burkhardt, G.; Bordignon, B.; Altié, A.; Young, P.; Bihel, F.; Fraterno, M.; Peiretti, F.; Fontes, M.
  Orphanet Journal of Rare Diseases 2015, 10, 56

2014

• Access to 4-Alkylaminopyridazine Derivatives via Nitrogen-Assisted Regioselective Pd-Catalyzed Reactions
  Blaise, E.;Kümmerle, A. E.;Hammoud, H.;de Araújo-Júnior, J. X.;Bihel, F.;Bourguignon, J.-J. and Schmitt, M.
  J Org Chem 2014, 79, 10311-10322

• t-BuXPhos: a highly efficient ligand for Buchwald-Hartwig coupling in water.
  Wagner, P.; Bollenbach, M.; Doebelin, C.; Bihel, F.; Bourguignon, J.-J.; Salome, C.; Schmitt, M.
  Green Chem 2014, 16 (9), 4170-4178.

• Structure-Activity Relationship Study around Guanabenz Identifies Two Derivatives Retaining Antiprion Activity but Having Lost alpha 2-Adrenergic Receptor Agonistic Activity
  Nguyen, P. H.;Hammoud, H.;Halliez, S.;Pang, Y. H.;Evrard, J.;Schmitt, M.;Oumata, N.;Bourguignon, J. J.;Sanyal, S.;Beringue, V.;Blondel, M.;Bihel, F. and Voisset, C.
  Acs Chemical Neuroscience 2014, 5, 1075-1082

• Buchwald-Hartwig reactions in water using surfactants
  Salome, C.; Wagner, P.; Bollenbach, M.; Bihel, F.; Bourguignon, J. J.; Schmitt, M.
  Tetrahedron 2014, 70 (21), 3413-3421.

• CamKII inhibitors reduce mitotic instability, connexon anomalies andp rogression of the in vivo behavioral phenotype in transgenic animals expressing a mutated Gjb1 gene.
  Mones, S.; Bordignon, B.; Peiretti, F.; Landrier, J. F.; Gess, B.; Bourguignon, J.-J.; Bihel, F.; Fontés, M.
  Frontiers in Neuroscience 2014, 8, 1-10.

• Fully Regiocontrolled Polyarylation of Pyridine
  Doebelin, C.; Wagner, P.; Bihel, F.; Humbert, N.; Kenfack, C. A.; Mely, Y.; Bourguignon, J. J.; Schmitt, M.
  J Org Chem 2014, 79 (3), 908-918.

2013

• The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction
  Klein, C.; Patte-Mensah, C.; Taleb, O.; Bourguignon, J. J.; Schmitt, M.; Bihel, F.; Maitre, M.; Mensah-Nyagan, A. G.
  Neuropharmacology 2013, 70, 254-260.

• N-Heteroarylation of Chiral alpha-Aminoesters by Means of Palladium-Catalyzed Buchwald-Hartwig Reaction.
  Hammoud, H.; Schmitt, M.; Blaise, E.; Bihel, F.; Bourguignon, J. J.
  J Org Chem 2013, 78 (16), 7930-7937.

• Endogenous mammalian RF-amide peptides, including PrRP, kisspeptin and 26RFa, modulate nociception and morphine analgesia via NPFF receptors
  Elhabazi, K.; Humbert, J. P.; Bertin, I.; Schmitt, M.; Bihel, F.; Bourguignon, J. J.; Bucher, B.; Becker, J. A. J.; Sorg, T.; Meziane, H.; Petit-Demouliere, B.; Ilien, B.; Simonin, F.
  Neuropharmacology 2013, 75, 164-171.

• Synthesis and Antiproliferative Effects of 5,6-Disubstituted Pyridazin-3(2H)-ones Designed as Conformationally Constrained Combretastatin A-4 Analogues
  Elagawany, M.; Schmitt, M.; Ghiaty, A.; El-Etrawy, A. S.; Ibrahim, M. A.; Bihel, F.; Sbardelotto, A. B.; Pessoa, C.; Nguyen, T. L.; Hamel, E.; Bourguignon, J. J.
  Anti-Cancer Agents inMed Chem 2013, 13 (7), 1133-1140.

• Trisubstitution of pyridine through sequential and regioselective palladium cross-coupling reactions affording analogs of known GPR54 antagonists
  Doebelin, C.; Wagner, P.; Bertin, I.; Simonin, F.; Schmitt, M.; Bihel, F.; Bourguignon, J. J.
  Rsc Adv 2013, 3 (26), 10296-10300.

• Nucleophilic Substitution of Azide Acting as a Pseudo Leaving Group: One-Step Synthesis of Various Aza Heterocycles
  Doebelin, C.; Schmitt, M.; Antheaume, C.; Bourguignon, J. J.; Bihel, F.
  J Org Chem 2013, 78 (22), 11335-11341.

2012

• Direct Guanidinylation of Aryl and Heteroaryl Halides via Copper-Catalyzed Cross-Coupling Reaction
  Hammoud, H.; Schmitt, M.; Bihel, F.; Antheaume, C.; Bourguignon, J. J.
  J Org Chem 2012, 77 (1), 417-423

• Development of sub-nanomolar dipeptidic ligands of neuropeptide FF receptors
  Gealageas, R.; Schneider, S.; Humbert, J. P.; Bertin, I.; Schmitt, M.; Laboureyras, E.; Dugave, C.; Mollereau, C.; Simonnet, G.; Bourguignon, J. J.; Simonin, F.; Bihel, F.
  Bioorg Med Chem Lett 2012, 22 (24), 7471-7474

• Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments
  Elhabazi, K.; Trigo, J. M.; Mollereau, C.; Mouledous, L.; Zajac, J. M.; Bihel, F.; Schmitt, M.; Bourguignon, J. J.; Meziane, H.; Petit-demouliere, B.; Bockel, F.; Maldonado, R.; Simonin, F.
  Brit J Pharmacol 2012, 165 (2), 424-435.

• Palladium-Catalyzed Synthesis of Substituted Pyrido[2,3-d]pyridazines at Positions 5 and 8
  Ibrahim, M. A.; Blaise, E.; Lozach, O.; Szalata, C.; Schmitt, M.; El-Etrawy, A. A. S.; Elagawany, M.; El-Feky, S. A.; Abdel-Samii, Z. K.; Meijer, L.; Bourguignon, J. J.; Bihel, F.
  Synthesis-Stuttgart 2012, 44 (20), 3216-3224.

• 1-Phenyl-3H-2,3-benzodiazepin-4(5H)-one
  Ballo, D.; Bihel, F.; Doubia, M. L.; Essassi, E. M.; Ng, S. W.
  Acta Crystallographica Section E 2012, E68, o2443.

• Toward versatile methods leading to highly functionnalized imidazo [1,2-a]pyridines
  Basilio-Lopes, A; De Aquino Mendonca, T; Mongeot, A; Bourguignon, JJ; Schmitt, M
  Tetrahedron Lett 2012, 53(21), 2583-2587

• Design, Synthesis, and Pharmacological Evaluation of N-Acylhydrazones and Novel Conformationally Constrained Compounds as Selective and Potent Orally Active Phosphodiesterase-4 Inhibitors
  Kummerle, AE; Schmitt, M; Cardozo, SVS; Lugnier, C; Villa, P; Lopes, AB; Romeiro, NC; Justiniano, H; Martins, MA; Fraga, CAM; Bourguignon, JJ;  Barreiro, E.
  J Med Chem 2012, 55(17), 7525-7545

• Protein-protein and protein-membrane associations in the lignin pathway
  Bassard, JE; Richert, L; Geerinck, J; Renault, H; Duval, F; Ullmann, P; Schmitt, M; Meyer, E; Mutterer, J; Boerjan, W; Werck, D.
  Plant Cell 2012, 24(11), 4465-4482

• Xanthurenic acid binds to neuronal G-protein-coupled receptors that secondarily activate cationic channels in the cell line NCB-20
  Taleb, O; Maammar, M; Brumaru, D; Bourguignon, JJ; Schmitt, M; Klein, C; Kemmel, V; Maitre, M; Mensah-Nyagan, AG
  PLoS One 2012, 7(11), e48553

• Synthesis, sigma(1), sigma(2)-receptors binding affinity and antiproliferative action of new C1-substituted adamantanes
  Riganas, S; Papanastasiou, I; Foscolos, GB; Tsotinis, A; Bourguignon, JJ; Serin, G; Mirjolet, JF; Dimas, K; Kourafalos, VN; Eleutheriades, A; Moutsos, VI; Khan, H; Georgakopoulou, S; Zaniou, A; Prassa, M; Theodoropoulou, M; Pondiki, St; Vamvakides, A.
  Bioorg  Med Chem 2012, 20(10), 3323-3331

• Novel access to 1,4-benzodiazepin-2-ones via the Buchwald reaction and application to the synthesis of novel heterocyclics
  Salome, C; Schmitt, M; Bourguignon, JJ.
  Tetrahedron Lett 2012, 53(9), 1033-1035

• Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor
  Keravis, T; Monneaux, F; Yougbare, I; Gazin, L; Bourguignon, JJ; Muller, S; Lugnier, C.
  PLoS One 2012, 7(1), e28899

2011

• New PDE4 inhibitors based on pharmacophoric similarity between papaverine and tofisopam
  Bihel, F. J. J.;Justiniano, H.;Schmitt, M.;Hellal, M.;Ibrahim, M. A.;Lugnier, C. and Bourguignon, J. J.
  Bioorganic & Medicinal Chemistry Letters 2011, 21, 6567-6572

2010

• Pharmacological characterization of the mouse NPFF2 receptor
  Talmont, F.;Mouledous, L.;Piedra-Garcia, L.;Schmitt, M.;Bihel, F.;Bourguignon, J. J.;Zajac, J. M. and Mollereau, C.
  Peptides 2010, 31, 215-220

• Prefrontal cortex and reversion of atropine-induced disruption of the degraded contingency effect by antipsychotic agents and N-desmethylclozapine in rats
  Carnicella, S.;Mongeot, A.;Bourguignon, J. J. and Oberling, P.
  International Journal of Neuropsychopharmacology 2010, 13, 109-122

2009

• The flavonoid dioclein is a selective inhibitor of cyclic nucleotide phosphodiesterase type 1 (PDE1) and a cGMP-dependent protein kinase (PKG) vasorelaxant in human vascular tissue
  Goncalves, R. L.;Lugnier, C.;Keravis, T.;Lopes, M. J.;Fantini, F. A.;Schmitt, M.;Cortes, S. F. and Lemos, V. S.
  European Journal of Pharmacology 2009, 620, 78-83

• Evolution of a Novel Phenolic Pathway for Pollen Development
  Matsuno, M.;Compagnon, V.;Schoch, G. A.;Schmitt, M.;Debayle, D.;Bassard, J. E.;Pollet, B.;Hehn, A.;Heintz, D.;Ullmann, P.;Lapierre, C.;Bernier, F.;Ehlting, J. and Werck-Reichhart, D.
  Science 2009, 325, 1688-1692

• Design, synthesis and analgesic properties of novel conformationally-restricted N-acylhydrazones (NAH)
  Kummerle, A. E.;Vieira, M. M.;Schmitt, M.;Miranda, A. L. P.;Fraga, C. A. M.;Bourguignon, J. J. and Barreiro, E. J.
  Bioorganic & Medicinal Chemistry Letters 2009, 19, 4963-4966

• Complexation with beta-cyclodextrin confers oral activity on the flavonoid dioclein
  Rezende, B. A.;Cortes, S. F.;De Sousa, F. B.;Lula, I. S.;Schmitt, M.;Sinisterra, R. D. and Lemos, V. S.
  International Journal of Pharmaceutics 2009, 367, 133-139

• Rapid synthesis of imidazo[4,5-b]pyridine containing polycyclics by means of palladium-catalyzed amidation of 2-chloro-3-nitropyridine
  Salome, C.;Schmitt, M. and Bourguignon, J. J.
  Tetrahedron Letters 2009, 50, 3798-3800

2008

• Cyclic nucleotide phosphodiesterase type 4 inhibitors: Evaluation of pyrazolo[1,5-a]-1,3,5-triazine ring system as an adenine bioisostere
  Raboisson, P.;Schultz, D.;Muller, C.;Reimund, J. M.;Pinna, G.;Mathieu, R.;Bernard, P.;Do, Q. T.;DesJarlais, R. L.;Justiano, H.;Lugnier, C. and Bourguignon, J. J.
  European Journal of Medicinal Chemistry 2008, 43, 816-829

• 6-endo-dig Cyclization of heteroarylesters to alkynes promoted by Lewis acid catalyst in the presence of Bronsted acid
  Hellal, M.;Bourguignon, J. J. and Bihel, F. J. J.
  Tetrahedron Letters 2008, 49, 62-65

2007

• Synthesis and reactivity of 2,3-dihydro-1H-2,3-benzodiazepine-1,4(5H)-dione
  Bihel, F. J. J.;Hellal, M. and Bourguignon, J. J.
  Synthesis-Stuttgart 2007, 24, 3791-3796

• A novel, conformation-specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties
  Maillet, E. L.;Pellegrini, N.;Valant, C.;Bucher, B.;Hibert, M.;Bourguignon, J. J. and Galzi, J. L.
  Faseb Journal 2007, 21, 2124-2134

• Neuropeptide FF and neuropeptide VF inhibit GABAergic neurotransmission in parvocellular neurons of the rat hypothalamic paraventricular nucleus
  Jhamandas, J. H.;Simonin, F.;Bourguignon, J. J. and Harris, K. H.
  American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2007, 292, R1872-R1880

• Synthesis of regiospecifically polysubstituted pyridazinones
  de Araujo-Junior, J. X.;Schmitt, M.;Antheaume, C. and Bourguignon, J. J.
  Tetrahedron Letters 2007, 48, 7817-7820

• 2-Amino-6-iodo-4-tosyloxypyrimidine: a versatile key intermediate for regioselective functionalization of 2-aminopyrimidines in 4-and 6-positions
  Benderitter, P.;de Arajo, J. X.;Schmitt, M. and Bourguignon, J. J.
  Tetrahedron 2007, 63, 12465-12470

• Isolation and NMR characterization of the indolomonoterpenoid alkaloids from Aspidosperma pyrifolium.
  de Araujo-Junior, J. X.; Antheaume, C.; Trindade, C.; Schmitt, M.; Bourguignon, J. J. and Santana AEG
  Phytochem. Rev., 2007, 6, 183-188

2006

• Microwave-assisted cyclic amidine synthesis using TiCl4
  Hellal, M.;Bihel, F.;Mongeot, A. and Bourguignon, J. J.
  Organic & Biomolecular Chemistry 2006, 4, 3142-3146

• Antiarrhythmogenic and antioxidant effect of the flavonoid dioclein in a model of cardiac ischemia/reperfusion
  Vianna, HR.; Cortes, SF.; Ferreira, AJ.; Capettini, LSA.; Schmitt, M.; Almeida, AP.; Massensini, AR. and Lemos, VS.
  Planta Med., 2006, 72 (4), 300-303

• RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia
  Simonin, F.;Schmitt, M.;Laulin, J. P.;Laboureyras, E.;Jhamandas, J. H.;MacTavish, D.;Matifas, A.;Mollereau, C.;Laurent, P.;Parmentier, M.;Kieffer, B. L.;Bourguignon, J. J. and Simonnet, G.
  Proceedings of the National Academy of Sciences of the United States of America 2006, 103, 466-471

• Sequential regio and chemoselective cross-coupling reactions by means of O-6-tri-isopropylsulfonate of 4-bromo-pyridazine 3,6-dione
  de Araujo-Junior, J. X.;Schmitt, M.;Benderitter, P. and Bourguignon, J. J.
  Tetrahedron Letters 2006, 47, 6125-6128

• Use of 4-bromo pyridazine 3,6-dione for building 3-amino pyridazine libraries
  Schmitt, M.;de Araujo-Junior, J. X.;Oumouch, S. and Bourguignon, J. J.
  Molecular Diversity 2006, 10, 429-434

• Stereoselective synthesis of 3 '-substituted 2 '-deoxy C-nucleoside pyrazolo[1,5-a]-1,3,5-triazines and their 5 '-phosphate nucleotides
  Mathieu, R.;Schmitt, M. and Bourguignon, J. J.
  Tetrahedron Letters 2006, 47, 5099-5103

• Use of polyfunctionalized pyridazines as reactive species for building chemical diversity
  Bourguignon, J. J.;Oumouch, S. and Schmitt, M.
  Current Organic Chemistry 2006, 10, 277-295